ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,505Medicare Part D Prescriptions Filled, Including Refills

Rank: 338 out of 2456

$391K Total Retail Price of All Prescriptions

Rank: 363 out of 2456

576 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 576 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 576 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,820 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 368 277 1 1
SIMVASTATIN 328 273 2 2
OMEPRAZOLE 229 169 3 3
METOPROLOL TARTRATE 210 193 4 10
ATENOLOL 210 196 4 6
AMLODIPINE BESYLATE 201 166 6 5
LEVOTHYROXINE SODIUM 192 171 7 4
HYDROCHLOROTHIAZIDE 176 149 8 7
ATORVASTATIN CALCIUM 170 140 9 12
HYDROCODONE-ACETAMINOPHEN 164 116 S3 10 20
ALENDRONATE SODIUM 159 154 11 19
FUROSEMIDE 154 133 12 8
GABAPENTIN 148 113 13 16
PRAVASTATIN SODIUM 144 129 14 15
METFORMIN HCL 141 97 15 11
WARFARIN SODIUM 112 101 16 9
GLIPIZIDE 84 68 17 46
PREDNISONE 76 59 18 39
ZOLPIDEM TARTRATE 75 65 19 28
DONEPEZIL HCL 75 75 19 23
CITALOPRAM HBR 74 52 21 14
PEN NEEDLE 74 51 21 150
LANTUS 71 37 23 44
LOSARTAN POTASSIUM 70 64 24 18
TAMSULOSIN HCL 68 60 25 32
FLOVENT HFA 67 30 26 104
TRAZODONE HCL 66 51 27 17
PROAIR HFA 66 43 27 22
CRESTOR 65 45 29 25
LANTUS SOLOSTAR 63 45 30 136
OXYCODONE-ACETAMINOPHEN 63 26 S2 30 35
ISOSORBIDE MONONITRATE ER 61 56 32 48
NAMENDA 59 59 33 42
AZITHROMYCIN 58 46 34 60
MIRTAZAPINE 58 56 34 29
OXYCODONE HCL 56 30 S2 36 38
SERTRALINE HCL 55 48 37 21
CYCLOBENZAPRINE HCL 53 32 R 38 77
RANITIDINE HCL 52 40 39 31
DIGOXIN 52 52 39 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.